Shen C, Tsai Y, Chou S, Chang Y, Tarn W
Commun Biol. 2024; 7(1):1712.
PMID: 39738787
PMC: 11685446.
DOI: 10.1038/s42003-024-07328-6.
Lee H, Lim H, He H, Lau C, Zheng C
PLoS Genet. 2024; 20(10):e1011276.
PMID: 39423233
PMC: 11524483.
DOI: 10.1371/journal.pgen.1011276.
Dando O, McQueen J, Burr K, Kind P, Chandran S, Hardingham G
Front Mol Neurosci. 2024; 17:1392408.
PMID: 39268251
PMC: 11390650.
DOI: 10.3389/fnmol.2024.1392408.
Moakley D, Campbell M, Anglada-Girotto M, Feng H, Califano A, Au E
bioRxiv. 2024; .
PMID: 38915499
PMC: 11195221.
DOI: 10.1101/2024.06.13.597128.
Liu L, Nguyen H, Das U, Ogunsola S, Yu J, Lei L
Nucleic Acids Res. 2024; 52(12):7211-7224.
PMID: 38661216
PMC: 11229381.
DOI: 10.1093/nar/gkae311.
Single-cell long-read sequencing-based mapping reveals specialized splicing patterns in developing and adult mouse and human brain.
Joglekar A, Hu W, Zhang B, Narykov O, Diekhans M, Marrocco J
Nat Neurosci. 2024; 27(6):1051-1063.
PMID: 38594596
PMC: 11156538.
DOI: 10.1038/s41593-024-01616-4.
Unique transcriptomes of sensory and non-sensory neurons: insights from Splicing Regulatory States.
Ciampi L, Serrano L, Irimia M
Mol Syst Biol. 2024; 20(4):296-310.
PMID: 38438733
PMC: 10987577.
DOI: 10.1038/s44320-024-00020-1.
Specification of neural circuit architecture shaped by context-dependent patterned LAR-RPTP microexons.
Han K, Yoon T, Kim J, Lee J, Lee J, Jang G
Nat Commun. 2024; 15(1):1624.
PMID: 38388459
PMC: 10883964.
DOI: 10.1038/s41467-024-45695-0.
Differential expression of paralog RNA binding proteins establishes a dynamic splicing program required for normal cerebral cortex development.
Cesari E, Farini D, Medici V, Ehrmann I, Guerra M, Testa E
Nucleic Acids Res. 2024; 52(8):4167-4184.
PMID: 38324473
PMC: 11077083.
DOI: 10.1093/nar/gkae071.
Detection of hidden intronic DDC variant in aromatic L-amino acid decarboxylase deficiency by adaptive sampling.
Koshimizu E, Kato M, Misawa K, Uchiyama Y, Tsuchida N, Hamanaka K
J Hum Genet. 2024; 69(3-4):153-157.
PMID: 38216729
DOI: 10.1038/s10038-023-01217-2.
Developmental synapse pathology triggered by maternal exposure to the herbicide glufosinate ammonium.
Izumi H, Demura M, Imai A, Ogawa R, Fukuchi M, Okubo T
Front Mol Neurosci. 2023; 16:1298238.
PMID: 38098940
PMC: 10720911.
DOI: 10.3389/fnmol.2023.1298238.
Orbitofrontal intronic circular RNA from Nrxn3 mediates reward learning and motivation for reward.
Dabrowski K, Floris G, Gillespie A, Daws S
Prog Neurobiol. 2023; 232:102546.
PMID: 38036039
PMC: 10843848.
DOI: 10.1016/j.pneurobio.2023.102546.
Phenotypic complexities of rare heterozygous neurexin-1 deletions.
Fernando M, Fan Y, Zhang Y, Tokolyi A, Murphy A, Kammourh S
bioRxiv. 2023; .
PMID: 37961635
PMC: 10634884.
DOI: 10.1101/2023.10.28.564543.
Sam68 is a druggable vulnerability point in cancer stem cells.
Mendes da Silva A, Yevdokimova V, Benoit Y
Cancer Metastasis Rev. 2023; 43(1):441-456.
PMID: 37792222
PMC: 11016129.
DOI: 10.1007/s10555-023-10145-8.
Nova proteins direct synaptic integration of somatostatin interneurons through activity-dependent alternative splicing.
Ibrahim L, Wamsley B, Alghamdi N, Yusuf N, Sevier E, Hairston A
Elife. 2023; 12.
PMID: 37347149
PMC: 10287156.
DOI: 10.7554/eLife.86842.
RNA epitranscriptomics dysregulation: A major determinant for significantly increased risk of ASD pathogenesis.
Beopoulos A, Gea M, Fasano A, Iris F
Front Neurosci. 2023; 17:1101422.
PMID: 36875672
PMC: 9978375.
DOI: 10.3389/fnins.2023.1101422.
Catsnap: a user-friendly algorithm for determining the conservation of protein variants reveals extensive parallelisms in the evolution of alternative splicing.
Timofeyenko K, Kanavalau D, Alexiou P, Kalyna M, Ruzicka K
New Phytol. 2023; 238(4):1722-1732.
PMID: 36751910
PMC: 10952736.
DOI: 10.1111/nph.18799.
Regionally restricted modulation of expression and alternative splicing in the hippocampus of a murine model of multiple sclerosis.
Adinolfi A, Di Sante G, Rivignani Vaccari L, Tredicine M, Ria F, Bonvissuto D
Front Mol Neurosci. 2023; 15:1073627.
PMID: 36710925
PMC: 9878567.
DOI: 10.3389/fnmol.2022.1073627.
Programmable macromolecule-based RNA-targeting therapies to treat human neurological disorders.
Morelli K, Smargon A, Yeo G
RNA. 2023; 29(4):489-497.
PMID: 36693761
PMC: 10019361.
DOI: 10.1261/rna.079519.122.
Neurexins and their ligands at inhibitory synapses.
Boxer E, Aoto J
Front Synaptic Neurosci. 2023; 14:1087238.
PMID: 36618530
PMC: 9812575.
DOI: 10.3389/fnsyn.2022.1087238.